Annual ROE
161.93%
+289.92%+226.52%
December 31, 2023
Summary
- As of February 26, 2025, ADCT annual return on equity is 161.93%, with the most recent change of +289.92% (+226.52%) on December 31, 2023.
- During the last 3 years, ADCT annual ROE has risen by +272.21% (+246.84%).
- ADCT annual ROE is now at all-time high.
Performance
ADCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
131.30%
-31.34%-19.27%
September 30, 2024
Summary
- As of February 26, 2025, ADCT quarterly return on equity is 131.30%, with the most recent change of -31.34% (-19.27%) on September 30, 2024.
- Over the past year, ADCT quarterly ROE has stayed the same.
- ADCT quarterly ROE is now -76.30% below its all-time high of 553.97%, reached on December 31, 2023.
Performance
ADCT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ADCT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +226.5% | 0.0% |
| 3 y3 years | +246.8% | +240.5% |
| 5 y5 years | +346.9% | +240.5% |
ADCT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +226.5% | -76.3% | +123.2% |
| 5 y | 5-year | at high | +226.5% | -76.3% | +123.2% |
| alltime | all time | at high | +226.5% | -76.3% | +123.2% |
ADC Therapeutics SA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 131.30%(-19.3%) |
| Jun 2024 | - | 162.64%(-27.5%) |
| Mar 2024 | - | 224.22%(-59.5%) |
| Dec 2023 | 161.93%(-226.5%) | 553.97%(-197.7%) |
| Sep 2023 | - | -567.10%(+102.2%) |
| Jun 2023 | - | -280.50%(+40.3%) |
| Mar 2023 | - | -199.87%(+59.8%) |
| Dec 2022 | -127.99%(+39.5%) | -125.04%(+10.9%) |
| Sep 2022 | - | -112.76%(+5.6%) |
| Jun 2022 | - | -106.80%(+15.8%) |
| Mar 2022 | - | -92.24%(-1.3%) |
| Dec 2021 | -91.72% | -93.45%(+7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -87.31%(+26.4%) |
| Jun 2021 | - | -69.10%(-28.4%) |
| Mar 2021 | - | -96.56%(-6.1%) |
| Dec 2020 | -110.28%(+12.4%) | -102.88%(-9.9%) |
| Sep 2020 | - | -114.22%(-26.2%) |
| Jun 2020 | - | -154.76%(+67.7%) |
| Mar 2020 | - | -92.31%(+48.3%) |
| Dec 2019 | -98.13%(+49.6%) | - |
| Dec 2019 | - | -62.23%(+73.1%) |
| Sep 2019 | - | -35.95%(+134.2%) |
| Jun 2019 | - | -15.35% |
| Dec 2018 | -65.58%(+42.3%) | - |
| Dec 2017 | -46.08% | - |
FAQ
- What is ADC Therapeutics SA annual return on equity?
- What is the all time high annual ROE for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual ROE year-on-year change?
- What is ADC Therapeutics SA quarterly return on equity?
- What is the all time high quarterly ROE for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly ROE year-on-year change?
What is ADC Therapeutics SA annual return on equity?
The current annual ROE of ADCT is 161.93%
What is the all time high annual ROE for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual return on equity is 161.93%
What is ADC Therapeutics SA annual ROE year-on-year change?
Over the past year, ADCT annual return on equity has changed by +289.92% (+226.52%)
What is ADC Therapeutics SA quarterly return on equity?
The current quarterly ROE of ADCT is 131.30%
What is the all time high quarterly ROE for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly return on equity is 553.97%
What is ADC Therapeutics SA quarterly ROE year-on-year change?
Over the past year, ADCT quarterly return on equity has changed by 0.00% (0.00%)